Anniversaries serve as a moment to reflect on life’s milestones, whether those milestones be personal, professional or global. But they also serve as an opportunity to look forward and examine how we can build upon what we’ve experienced to improve in the years ahead. For many, March marks the anniversary of an event that not only changed the world, but the trajectory of many lives. On March 11, 2020, the World Health Organization’s Director-General classified COVID-19 as a pandemic. Abbott scientists had been on the front lines since sequences were made available in early 2020 and their work helped us develop and deploy more than a billion tests globally to mitigate the spread of the virus. Though, that’s not the beginning nor the end of our infectious disease story. A Look Back Building on nearly 30 years of history in hunting both new and evolving viruses like HIV and hepatitis, Abbott Virus Hunters sprang into action against COVID-19 knowing that the world needed diagnostic solutions. Their sequencing work and dedication to accuracy and precision helped Abbott’s research and development teams as we launched 12 tests for SARS-CoV-2 across the globe* in one year, ranging from molecular to antigen to antibody. Still, viruses never stop. There was more work to be done. Within a few decades, Duke’s Global Health Institute estimates that novel disease outbreaks will likely increase three-fold, driven by globalization, population growth and closer contact between humans and animals. As our Virus Hunters know, the next pandemic is only a plane ride away. It became clear that, to prevent history from repeating itself, global collaboration was necessary. That’s why, on March 11, 2021, they launched the Abbott Pandemic Defense Coalition — a first-of-its-kind, industry-led global scientific network dedicated to the early detection of, and rapid response to, future pandemic threats — to stay a step ahead of known and emerging viruses and variants, including SARS-CoV-2.